1
Aflibercept for Relapsed Multiple Myeloma
Condition(s):Stage II Multiple Myeloma; Stage III Multiple MyelomaLast Updated:February 8, 2021Terminated
Stage II Multiple Myeloma: 887 Clinical Trials, Page 1 of 89
Hide Studies Not Open or Pending
2
Chemotherapy With or Without Wobe-Mugos E in Treating Patients With Stage II or Stage III Multiple Myeloma
Condition(s):Multiple Myeloma and Plasma Cell NeoplasmLast Updated:December 18, 2013Unknown status
3
Bevacizumab, Lenalidomide, and Dexamethasone in Patients With Relapsed or Refractory Stage II or III Multiple Myeloma
Condition(s):Multiple Myeloma in Relapse; Stage II Multiple Myeloma; Stage III Multiple MyelomaLast Updated:September 1, 2017Completed
4
Bortezomib and Thalidomide in Treating Patients With Newly Diagnosed Stage II or Stage III Multiple Myeloma
Condition(s):Multiple MyelomaLast Updated:March 1, 2018Completed
5
Thalidomide, Doxorubicin, and Dexamethasone in Treating Patients With Untreated Stage II or Stage III Multiple Myeloma
Condition(s):Multiple Myeloma and Plasma Cell NeoplasmLast Updated:March 7, 2013Completed
6
Combination Chemotherapy in Treating Patients With Stage II or Stage III Multiple Myeloma
Condition(s):Multiple Myeloma and Plasma Cell NeoplasmLast Updated:May 15, 2013Completed
7
Melphalan and Amifostine Followed By One or Two Autologous or Syngeneic Stem Cell Transplants and Maintenance Therapy in Treating Patients With Stage II-III Multiple Myeloma
Condition(s):Refractory Multiple Myeloma; Stage II Multiple Myeloma; Stage III Multiple MyelomaLast Updated:August 21, 2015Completed
8
Vaccine Therapy in Treating Patients With Multiple Myeloma
Condition(s):Stage II Multiple Myeloma; Stage III Multiple Myeloma; Refractory Plasma Cell NeoplasmLast Updated:June 20, 2013Completed
9
Activated White Blood Cells With ASCT for Newly Diagnosed Multiple Myeloma
Condition(s):Multiple Myeloma and Plasma Cell NeoplasmLast Updated:December 19, 2018Completed
10
Combination Chemotherapy With or Without High Dose Cyclophosphamide and Recombinant Interferon Alfa-2b in Treating Patients With Previously Untreated Stage I-III Multiple Myeloma
Condition(s):Stage I Multiple Myeloma; Stage II Multiple Myeloma; Stage III Multiple MyelomaLast Updated:May 31, 2013Completed